Cytosorbents (OTCBB:CTSO) is a critical-care focused therapeutic device company using blood purification to modulate the immune system and fight organ failure in life-threatening illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis.  CytoSorbents’ flagship product CytoSorb® is a first-in-class extracorporeal cytokine filter now approved in the European Union. The company uses its technology for other key products in development such as HemoDefend, a development-stage blood purification technology.  For more information visit the company’s Web site at www.cytosorbents.com

Marcum offers an extensive range of professional services and a high degree of specialization. In addition to traditional accounting, assurance, and tax, including domestic and international tax planning and preparation, the firm’s professional services include mergers and acquisition planning, family office services, forensic accounting, and litigation support. For more information on Marcum, visit www.marcumllp.com

Let us hear your thoughts below: